Nuvation Bio (NUVB) Accounts Payables (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Accounts Payables of $22.4 million for Q1 2026, up 112.92% year-over-year from $10.5 million in Q1 2025, and up 136.68% quarter-over-quarter from $9.5 million in Q4 2025.
Nuvation Bio (NUVB) Accounts Payables (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Accounts Payables for 7 consecutive years, with $22.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 112.92% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (up 112.92% YoY), while the FY2025 annual figure was $9.5 million, up 49.32% from the prior year.
- Accounts Payables improved to $22.4 million in Q1 2026 per NUVB's latest filing, from $9.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $22.4 million in Q1 2026 and bottomed at $2.1 million in Q4 2022.
- Historically, Accounts Payables has averaged $8.5 million across 5 years, with a median of $6.3 million in 2024.
- Annual changes were most pronounced in 2023 — Accounts Payables slumped 79.75% — and 2024, when it jumped 421.7%.
- Nuvation Bio's Accounts Payables stood at $2.1 million in 2022, then advanced by 3.27% to $2.2 million in 2023, then surged by 187.37% to $6.3 million in 2024, then surged by 49.32% to $9.5 million in 2025, then soared by 136.68% to $22.4 million in 2026.
- Business Quant data shows NUVB's Accounts Payables at $22.4 million in Q1 2026, $9.5 million in Q4 2025, and $15.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 12.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.09 Mn |
| Mar 31, 2026 | 22.44 Mn |
| Dec 31, 2025 | 9.48 Mn |
| Sep 30, 2025 | 15.36 Mn |
| Jun 30, 2025 | 22.42 Mn |
| Mar 31, 2025 | 10.54 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Sep 30, 2024 | 12.38 Mn |
| Jun 30, 2024 | 5.21 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.58 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 12.73 Mn |
| Mar 31, 2022 | 9.67 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | 5.16 Mn |